Tom Brennan

Shorla Pharma Ltd. manufactures drugs in the oncology space for women’s and pediatric cancers. Its products include SH-111. The company was founded by Sharon Cunningham and Orlaith Ryan in 2018 and is headquartered in Clonmel, Ireland.

Shorla Pharma Ltd. manufactures drugs in the oncology space for women’s and pediatric cancers. Its products include SH-111. The company was founded by Sharon Cunningham and Orlaith Ryan in 2018 and is headquartered in Clonmel, Ireland.

EirGen Pharma Ltd. develops, manufactures and supplies pharmaceutical products. It specializes in advanced formulation development, global regulatory support services, clinical trial management, cytotoxic product production and niche product contract manufacturing. The company was founded by Tom Brennan and Patsy Carney in March 2005 and is headquartered in Waterford, Ireland.

EirGen Pharma Ltd. develops, manufactures and supplies pharmaceutical products. It specializes in advanced formulation development, global regulatory support services, clinical trial management, cytotoxic product production and niche product contract manufacturing. The company was founded by Tom Brennan and Patsy Carney in March 2005 and is headquartered in Waterford, Ireland.

EirGen Pharma Ltd. develops, manufactures and supplies pharmaceutical products. It specializes in advanced formulation development, global regulatory support services, clinical trial management, cytotoxic product production and niche product contract manufacturing. The company was founded by Tom Brennan and Patsy Carney in March 2005 and is headquartered in Waterford, Ireland.

EirGen Pharma Ltd. develops, manufactures and supplies pharmaceutical products. It specializes in advanced formulation development, global regulatory support services, clinical trial management, cytotoxic product production and niche product contract manufacturing. The company was founded by Tom Brennan and Patsy Carney in March 2005 and is headquartered in Waterford, Ireland.

Shorla Pharma Ltd. manufactures drugs in the oncology space for women’s and pediatric cancers. Its products include SH-111. The company was founded by Sharon Cunningham and Orlaith Ryan in 2018 and is headquartered in Clonmel, Ireland.

Shorla Pharma Ltd. manufactures drugs in the oncology space for women’s and pediatric cancers. Its products include SH-111. The company was founded by Sharon Cunningham and Orlaith Ryan in 2018 and is headquartered in Clonmel, Ireland.